Morgan Stanley raised the firm’s price target on Delek US (DK) to $40 from $34 and keeps an Equal Weight rating on the shares after Delek reported Q3 results last week and raised its Enterprise Optimization Plan savings guidance to at least $180M from $130M-$170M.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DK:
- Delek US price target raised to $47 from $39 at Piper Sandler
- Delek US price target raised to $36 from $28 at TD Cowen
- Delek US price target raised to $45 from $37 at Mizuho
- Delek US Holdings: Hold Rating Maintained Amid Improved Earnings and Future Uncertainties
- Delek US price target raised to $40 from $33 at Scotiabank